Inventors:
Robert L. Keith - Highlands Ranch CO, US
Mark W. Geraci - Aurora CO, US
York E. Miller - Denver CO, US
Assignee:
The Regents of the University of Colorado, a body corporate - Denver CO
International Classification:
A61K 31/19
Abstract:
The present invention provides a method for preventing or reducing the risk of cancer or the progression of premalignant dysplasia in a subject having a higher risk factor by administering a therapeutically effective amount of prostacyclin analog.